These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 37605814)
1. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study. Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571 [TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259 [TBL] [Abstract][Full Text] [Related]
4. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan. Fukuhara H; Hagiwara Y; Oba K; Inoue K Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis. Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832 [TBL] [Abstract][Full Text] [Related]
6. The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer. Nishimura N; Miyake M; Miyamoto T; Tomizawa M; Shimizu T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K Jpn J Clin Oncol; 2023 Mar; 53(4):343-348. PubMed ID: 36585780 [TBL] [Abstract][Full Text] [Related]
7. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer. Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K Int J Urol; 2024 Aug; 31(8):876-885. PubMed ID: 38687165 [TBL] [Abstract][Full Text] [Related]
8. 'Real-life experience': recurrence rate at 3 years with Hexvix Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385 [TBL] [Abstract][Full Text] [Related]
10. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889 [TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial. Yu G; Rice S; Heer R; Lewis R; Vadiveloo T; Mariappan P; Penegar S; Clark E; Tandogdu Z; Hall E; Vale L Eur Urol Open Sci; 2023 Jul; 53():67-77. PubMed ID: 37441343 [TBL] [Abstract][Full Text] [Related]
13. A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer. Heer R; Lewis R; Vadiveloo T; Yu G; Mariappan P; Cresswell J; McGrath J; Nabi G; Mostafid H; Lazarowicz H; Kelly J; Duncan A; Penegar S; Breckons M; Wilson L; Clark E; Feber A; Orozco-Leal G; Tandogdu Z; Taylor E; N'Dow J; Norrie J; Ramsay C; Rice S; Vale L; MacLennan G; Hall E NEJM Evid; 2022 Oct; 1(10):EVIDoa2200092. PubMed ID: 38319866 [TBL] [Abstract][Full Text] [Related]
14. Comparison of PDD-TURBT alone versus white light TURBT plus intravesical BCG therapy: A propensity-score matching study. Miyakawa J; Yamada Y; Hakozaki Y; Makino K; Kamei J; Taguchi S; Kawai T; Akiyama Y; Yamada D; Kume H Photodiagnosis Photodyn Ther; 2024 Aug; 48():104254. PubMed ID: 38901718 [TBL] [Abstract][Full Text] [Related]
15. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer. Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924 [TBL] [Abstract][Full Text] [Related]
16. Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results. de la Rosette J; Martov A; Hurle R; Favre G; Mamoulakis C; Castanheira de Oliveira M; Stenzl A; Linares-Espinós E; Trelles Guzmán CR; Gravas S; Knoll T; Boz MY; Herrmann T; Laguna P World J Urol; 2022 Mar; 40(3):727-738. PubMed ID: 34741631 [TBL] [Abstract][Full Text] [Related]
17. Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study. Arai T; Sazuka T; Oka R; Tsukamoto R; Sato H; Goto Y; Imamura Y; Sakamoto S; Ichikawa T Anticancer Res; 2023 Aug; 43(8):3615-3621. PubMed ID: 37500129 [TBL] [Abstract][Full Text] [Related]
18. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary? Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963 [No Abstract] [Full Text] [Related]
19. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J; Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]